A Narrative Review on the Administration of Inhaled Prostaglandins in Critically Ill Adult Patients With Acute Respiratory Distress Syndrome.

Lydia R Ware Christine S KimPaul M SzumitaJeremy R DeGrado

Published in: The Annals of pharmacotherapy (2023)

The use of iEPO and other inhaled prostaglandins requires further investigation to fully elucidate their effects on clinical outcomes, but it appears these medications may have a potential benefit in COVID-19-associated ARDS and non-COVID-19 ARDS patients with refractory hypoxemia but with little effect on mortality.

Keyphrases

acute respiratory distress syndrome
coronavirus disease
extracorporeal membrane oxygenation
sars cov
mechanical ventilation
cystic fibrosis
cardiovascular events
respiratory syndrome coronavirus
risk factors
risk assessment
human health
cardiovascular disease
climate change